To determine the seroprevalence of hepatitis B markers in chronic hepatitis B patients, 75 patients with chronic hepatitis B virus of ages (8-70) years have been investigated and compared with 50 apparently healthy individuals. All the studied groups were carried out to measure (HBsAg), (HBsAb), (HBeAg), (HBeAb), and (Total HBcAb) by Enzyme linked immunosorbent assay (ELISA) technique. The percentage distribution of HBsAg was (86.67%) and HBsAb was (1.33%) in sera of CHB patients and there were a highly significant differences (P<0.01) when compared between studied groups, while, the percentage distribution of HBeAg was (22.67%) in sera of CHB patients and the significant represent the difference in distribution of HBeAg as infection but not as HBsAg distribution. Whereas the percentage distribution of HBeAb was (50.67%) in sera of CHB patients and there were no significant differences (P>0.05) when compared between studied group. The statistical analysis also demonstrated that the percentage distribution of total HBc Ab was (73.33%) in sera of CHB patients and there were a highly significant differences (P<0.01) when compared between studied group. These results indicated that HBsAg was the predominant markers in patients with chronic hepatitis B virus.